{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:33:45Z","timestamp":1795059225540,"version":"4.10.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41440-021-00786-z","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T09:02:43Z","timestamp":1636448563000},"page":"360-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"45","author":[{"given":"Chia Siang","family":"Kow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Sangarran","family":"Ramachandram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shahzad","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"786_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chest.2021.01.073","volume":"160","author":"SR Mendez","year":"2021","unstructured":"Mendez SR, Frank RC, Stevenson EK, Chung M, Silverman MG. Dihydropyridine calcium channel blockers and the risk of severe COVID-19. Chest 2021;160:89\u201393.","journal-title":"Chest"},{"key":"786_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/emph\/eoaa046","volume":"9","author":"B Crespi","year":"2020","unstructured":"Crespi B, Alcock J. Conflicts over calcium and the treatment of COVID-19. Evol Med Public Health. 2020;9:149\u201356.","journal-title":"Evol Med Public Health"},{"key":"786_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3349\/ymj.2021.62.7.577","volume":"62","author":"TK Oh","year":"2021","unstructured":"Oh TK, Cho HW, Suh JW, Song IA. Incidence and mortality associated with cardiovascular medication among hypertensive COVID-19 patients in South Korea. Yonsei Med J. 2021;62:577\u201383.","journal-title":"Yonsei Med J"},{"key":"786_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000515232","volume":"52","author":"TT Choksi","year":"2021","unstructured":"Choksi TT, Zhang H, Chen T, Malhotra N. Outcomes of hospitalized COVID-19 patients receiving renin angiotensin system blockers and calcium channel blockers. Am J Nephrol. 2021;52:250\u201360.","journal-title":"Am J Nephrol"},{"key":"786_CR5","doi-asserted-by":"crossref","unstructured":"Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, et al. Association of antihypertensive agents with the risk of in-hospital death in patients with Covid-19 [published online ahead of print, 2021 Feb 17] [published correction appears in Cardiovasc Drugs Ther. 2021 Mar 4]. Cardiovasc Drugs Ther. 2021;1\u22126.","DOI":"10.1007\/s10557-021-07164-4"},{"key":"786_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/thoraxjnl-2020-215768","volume":"76","author":"CF Christiansen","year":"2021","unstructured":"Christiansen CF, Potteg\u00e5rd A, Heide-J\u00f8rgensen U, Bodilsen J, S\u00f8gaard OS, Maeng M, et al. SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis. Thorax 2021;76:370\u20139.","journal-title":"Thorax"},{"key":"786_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41421-020-00221-6","volume":"6","author":"F Yan","year":"2020","unstructured":"Yan F, Huang F, Xu J, Yang P, Qin Y, Lv J, et al. Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients. Cell Discov. 2020;6:77.","journal-title":"Cell Discov"},{"key":"786_CR8","doi-asserted-by":"publisher","first-page":"e20773","DOI":"10.2196\/20773","volume":"22","author":"A Neuraz","year":"2020","unstructured":"Neuraz A, Lerner I, Digan W, Paris N, Tsopra R, Rogier A, et al. Natural language processing for rapid response to emergent diseases: case study of calcium channel blockers and hypertension in the COVID-19 pandemic. J Med Internet Res. 2020;22:e20773.","journal-title":"J Med Internet Res"},{"key":"786_CR9","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/CM9.0000000000001479","volume":"134","author":"C Peng","year":"2021","unstructured":"Peng C, Wang H, Guo YF, Qi GY, Zhang CX, Chen T, et al. Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension. Chin Med J. 2021;134:1602\u20139.","journal-title":"Chin Med J"},{"key":"786_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jinf.2020.07.026","volume":"82","author":"QB Lu","year":"2021","unstructured":"Lu QB, Jiang WL, Zhang X, Li HJ, Zhang XA, Zeng HL, et al. Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case\u2212control study. J Infect. 2021;82:159\u201398.","journal-title":"J Infect"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00786-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T09:18:07Z","timestamp":1642497487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00786-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1038\/s41440-021-00786-z","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}